Figure 1: Localization of a possible insulinoma in the case patient. To exclude the possibility that lesions in the pancreatic tail were caused by an accessory spleen and to confirm the presence ...

Phase 3 registrational trial for ersodetug in patients with tumor hyperinsulinism (HI) expected to commence in 2025; real-world patient benefit demonstrated in Expanded Access ProgramREDWOOD CITY, ...

A molecule in lizard saliva may make it easier to find certain tumors in the pancreas.

The company is considering initiating studies for RZ358 in non-islet cell tumor hypoglycemia (NICTH) and insulinoma patients. This expansion into additional indications could create multiple revenue ...

The report describes how medical management was altered and how the patient was supported in order to alleviate these burdens. In particular, the report highlights the first documented use of flash ...

Uppsala University. "Patients may become unnecessarily depressed by common heart medicine." ScienceDaily. www.sciencedaily.com / releases / 2024 / 11 / 241111123249.htm (accessed November 29, 2024 ...

"This approach allows these patients to avoid the risks of urinary incontinence, erectile dysfunction and other potential side effects of surgery and radiation therapy." Conservative management ...

But about a third say they've never been asked. Physicians describe what this says about the doctor-patient relationship. "You never really know what the patient needs until they walk in the room ...

In 2021, a research team led by Prof. Heiko Lickert from Helmholtz Munich discovered the insulin-inhibitory receptor ...